Clonidine
Established medicineAlso known as Catapres, Chlorthalidone-Clonidine, Clorpres, Combipres+12 more
Catapres, Chlorthalidone-Clonidine, Clorpres, Combipres, Duraclon, Javadin, Kapvay, Nexiclon, Onyda, Clonidin, Clonidina, 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine, 2-((2,6-Dichlorophenyl)imino)imidazolidine, CloNIDine HCl, CloNIDine Hydrochloride, Clonidinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery
The PREVENT AGITATION Trial II - Children ≤1 Year
Treatment of Orthostatic Intolerance
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- ClinicalTrials.gov — clinical trials